(Q43481756)

English

Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial

scientific article published in April 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M C Genovese

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

S Bojin

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

I M Biagini

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

E Mociran

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

D Cristei

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

G Mirea

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

L Georgescu

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

J Sloan-Lancaster

8

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

publication date

1 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

880-889

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Roles of B cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

The TNF family members BAFF and APRIL: the growing complexity

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

Aberrant activation of B cells in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial

1 reference

https://api.crossref.org/works/10.1002%2FART.37820

21 January 2018

Identifiers

10.1002/ART.37820

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43481756&oldid=1989741023"